Elevance Health, Inc.
ELV
$433.27
-$3.10-0.71%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 1.58% | -2.76% | 3.92% | -2.15% | -3.44% |
| Total Depreciation and Amortization | -1.49% | 10.96% | 24.87% | 32.14% | 31.70% |
| Total Amortization of Deferred Charges | 14.36% | 23.51% | 23.51% | 23.51% | 23.51% |
| Total Other Non-Cash Items | 112.29% | 760.33% | 167.92% | 250.00% | 273.19% |
| Change in Net Operating Assets | -226.48% | -81.74% | 121.54% | 272.69% | -64.54% |
| Cash from Operations | -4.02% | -17.90% | 28.97% | 46.75% | 0.42% |
| Capital Expenditure | -12.50% | -6.20% | -9.33% | -5.45% | -5.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -139.14% | -142.92% | -162.99% | 36.58% | 81.33% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.27% | 64.93% | 55.69% | 35.69% | 45.64% |
| Cash from Investing | -22.19% | 26.84% | 19.87% | 30.79% | 52.69% |
| Total Debt Issued | -48.63% | -7.42% | -20.32% | 163.86% | -2.11% |
| Total Debt Repaid | 37.02% | -5.87% | -1.01% | -164.13% | -43.30% |
| Issuance of Common Stock | -16.48% | -26.80% | -17.42% | -21.58% | -10.34% |
| Repurchase of Common Stock | -15.19% | -2.33% | -12.51% | -19.24% | -20.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.51% | -13.12% | -12.43% | -11.88% | -11.32% |
| Other Financing Activities | -82.93% | -14.29% | 38.46% | 127.34% | 51.85% |
| Cash from Financing | -154.10% | -35.28% | -78.15% | 17.86% | -411.58% |
| Foreign Exchange rate Adjustments | 92.86% | 100.00% | 84.62% | 30.77% | -40.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -134.34% | -39.47% | 195.08% | 225.78% | 391.17% |
